AI app aims to cut heart attack deaths by getting Clot-Busting drugs to patients faster
NCT ID NCT07160491
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether an artificial intelligence (AI) mobile app can help doctors give clot-busting medicine earlier to people having a severe heart attack (STEMI) when a hospital procedure isn't possible within 2 hours. About 3,356 participants will be randomly assigned to get either standard care or care guided by the app. The goal is to see if the app reduces deaths, strokes, and other major heart problems over one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tenecteplase (clot-busting drug) and an AI-assisted mobile app to guide treatment
What this could lead to
If successful, this could provide a reliable way to deliver faster, life-saving heart attack treatment in remote areas or when hospital procedures are delayed.
What could go wrong
This is a large trial, but the AI app is new and unproven. The benefit depends on how well it works in real-world settings, and there are always risks with clot-busting drugs, like bleeding.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEMI - ST ELEVATION MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
No. 83, Wenhua Road, Shenhe District, Shenyang City
RECRUITINGShenyang, Liaoning, China
Contact Phone: •••-•••-•••• Email: •••••@•••••